Sustained Efficacy, Safety and High Adherence Rate of Onabotulinum Toxin Type A in Chronic Migraine Patients: A Multicentric Prospective Real-Life Study

Guidelines regarding long-term use with onabotulinumtoxinA (onaBT-A) in chronic migraine (CM) prophylaxis are lacking. This multicentric prospective real-life study aimed to assess the efficacy and safety of a long-term treatment. A total of 195 chronic migraine patients were treated with onaBT-A, e...

Descripción completa

Detalles Bibliográficos
Autores principales: Corbelli, Ilenia, Verzina, Angela, Leone De Magistris, Ilaria, De Vanna, Gioacchino, Eusebi, Paolo, Mataluni, Giorgia, Pisani, Antonio, Prudenzano, Addolorata Maria Pia, Trojano, Maria, Delussi, Marianna, De Tommaso, Marina, Russo, Antonio, Silvestro, Marcello, Tedeschi, Gioacchino, Calabresi, Paolo, Sarchielli, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863104/
https://www.ncbi.nlm.nih.gov/pubmed/36668854
http://dx.doi.org/10.3390/toxins15010034

Ejemplares similares

Ejemplares similares